Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting session of oropharyngeal cancer in association with HPV status of the patients. In this webinar, the speaker, Dr. Ashish M Kaushal, and Dr. Tejinder Singh has shared the important facts associated with head and neck cancer.
Oropharyngeal cancers are common in men as smoking is one of the primary reasons for having this disease. Also, being infected with human papillomavirus (HPV) can increase the risk of oropharyngeal cancer. Signs and symptoms of oropharyngeal cancer include a lump in the neck and a sore throat
HPV status is associated with the occurrence of cancer at the back of the throat, including the base of the tongue and tonsils. About 70% of oropharyngeal cancers occur in HPV positive individuals. However, HPV negative patients can also have head and neck cancers. Learn more about them through case studies in this session
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Study supports routine brain MRI screening in asymptomatic late-stage breast cancer patients
2.
Preferred and Actual Location of Death Often Don't Match for Young Cancer Patients
3.
Childhood cancer survivors face new health problems later in life, study shows
4.
In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.
5.
In 18 States, alcohol exclusion laws are still in effect.
1.
Cold Antibody AIHA and Neoplastic Disorders: Unraveling the Clinical and Pathogenic Link
2.
Optimizing Platelet Transfusions: Balancing Benefits and Risks in Modern Hematology
3.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
4.
Cancer Trials 2025: Vaccines, Metabolic Targets, and the Microbiome in Oncology
5.
Unleashing the Inner Predator: Reprogramming Macrophages to Conquer Cancer Immunotherapy
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
4.
Navigating the Complexities of Ph Negative ALL - Part XVI
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation